CB Therapeutics
Fermentation-derived natural products to solve health problems
CB Therapeutics is a synthetic biology company focused on bringing cannabinoid and tryptamine therapeutics to the clinic and commercial markets to treat depression, PTSD, opioid addiction, alcoholism, pain, and other mental health problems.
Latest News
Active Founders
Sher Butt, CEO
Jacob Vogan
I'm focused on improving the human condition by driving scientific research and products which treat mental health disorders, increase our healthspan, and promote longevity. I've worked at UC Davis and UCSF as a researcher. I completed my PhD and postdoc at UC Berkeley. I co-founded CB Therapeutics with the goal of developing a synthetic biology solution to deliver affordable CBD, which has now expanded into novel cannabinoids and tryptamines, like psilocybin, to treat myriad health issues.
